Eagle Pharmaceuticals, Teva sales and marketing update

Teva launched Bendeka bendamustine in the U.S. to treat chronic lymphocytic leukemia (CLL) and indolent B cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within six months of treatmen...